Liver carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Dietary alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells.
|
14563831 |
2004 |
Liver carcinoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis.
|
30638930 |
2019 |
Diabetes Mellitus, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin.
|
20973890 |
2011 |
Hypercholesterolemia
|
0.200 |
Biomarker
|
disease |
RGD |
Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia.
|
16741953 |
2006 |
Arteriosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE<sup>-/-</sup> Mice Fed with a High-Fat Diet.
|
28491104 |
2017 |
Arteriosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Both SREBP-2 and SCAP are candidates to contribute to the development of atherosclerosis.
|
16466730 |
2006 |
Arteriosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE<sup>-/-</sup> mice.
|
30462530 |
2019 |
Atherosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE<sup>-/-</sup> Mice Fed with a High-Fat Diet.
|
28491104 |
2017 |
Atherosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE<sup>-/-</sup> mice.
|
30462530 |
2019 |
Atherosclerosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Both SREBP-2 and SCAP are candidates to contribute to the development of atherosclerosis.
|
16466730 |
2006 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our study reveals a previously unrecognized negative feedback loop in SCAP/SREBP-1 signaling mediated by miR-29 and suggests that miR-29 treatment may represent an effective means to target GBM.
|
27477273 |
2016 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Xenograft studies reveal that blocking SCAP N-glycosylation ameliorates EGFRvIII-driven glioblastoma growth.
|
26555173 |
2015 |
Metabolic Syndrome X
|
0.020 |
Biomarker
|
disease |
BEFREE |
We explored the association between the variants of the sterol-regulatory element-binding transcription factor-1 (SREBF1) gene and the SREBP cleavage-activation protein (SCAP) gene with AAP-induced MetS in a genetic case-control study.
|
26982812 |
2016 |
Metabolic Syndrome X
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Effect of an SNP in SCAP gene on lipid-lowering response to rosuvastatin in Indian patients with metabolic syndrome.
|
27885915 |
2016 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
Xenograft studies reveal that blocking SCAP N-glycosylation ameliorates EGFRvIII-driven glioblastoma growth.
|
26555173 |
2015 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our study reveals a previously unrecognized negative feedback loop in SCAP/SREBP-1 signaling mediated by miR-29 and suggests that miR-29 treatment may represent an effective means to target GBM.
|
27477273 |
2016 |
Malignant neoplasm of urinary bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, Targeting SCAP may provide a promising means of treating BC and a new perspective for the tumorigenesis of bladder cancer.
|
31360104 |
2019 |
Bladder Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, Targeting SCAP may provide a promising means of treating BC and a new perspective for the tumorigenesis of bladder cancer.
|
31360104 |
2019 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Accordingly, targeting of SREBP-2 with Fatostatin which specifically inhibits SCAP (SREBP cleavage-activating protein) and prevents SREBP activation, attenuated breast cancer-induced osteolysis in vivo.
|
30394316 |
2019 |
Coronary heart disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We conducted a case-control study to investigate whether the common variants of genes from the SREBP2 activating-related pathway, involving SREBP2, SCAP, INSIG1 and INSIG2 genes, were associated with coronary heart disease (CHD) of Chinese Han population individually or interactively.
|
19740467 |
2010 |
Dental Pulp Necrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Apical papilla represents a source of an enriched mesenchymal stem cell (MSC) population (stem cells of the apical papilla [SCAPs]) that modulates root development and may participate in regenerative endodontic procedures in immature teeth with pulp necrosis.
|
28190588 |
2017 |
Myocardial Infarction
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction.
|
17383658 |
2008 |
Myocardial Infarction
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction.
|
17383658 |
2008 |
Adrenoleukodystrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
We used fish which harbor a mutation in the gene encoding the membrane bound transcription factor protease 1 (mbtps1; also called site-1 protease) and embryos in which the Srebp cleavage activating protein (scap) is knocked down to determine the requirement of this pathway in acute ALD.
|
21284674 |
2011 |
Adult Liver Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
RA-XII Suppresses the Development and Growth of Liver Cancer by Inhibition of Lipogenesis via SCAP-dependent SREBP Supression.
|
31083642 |
2019 |